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Abstract: 
We have demonstrated atomically thin, quantum capacitance-limited, field-effect transistors 
(FETs) that enable the detection of pH changes with »75-fold higher sensitivity (4.4 V/pH) over 
the Nernst value of 59 mV/pH at room temperature when used as a biosensor. The transistors,  
which are fabricated from a monolayer of MoS2  with a room temperature ionic liquid (RTIL) in 
place of a conventional oxide gate dielectric, exhibit very low intrinsic noise resulting in a pH 
limit of detection (LOD) of 92´10-6 at 10 Hz. This high device performance, which is a function 
of the structure of our device, is achieved by remotely connecting the  gate to a pH sensing 
element allowing the FETs to be reused. Because pH measurements are fundamentally important 
in biotechnology, the low limit of detection demonstrated here will benefit numerous 
applications ranging from pharmaceutical manufacturing to clinical diagnostics. As an example, 
we experimentally quantified the function of the kinase Cdk5, an enzyme implicated in 
Alzheimer’s disease, at concentrations that are 5-fold lower than physiological values, and with 
sufficient time-resolution to allow the estimation of both steady-state and kinetic parameters in a 
single experiment. The high sensitivity, low LOD and fast turnaround time of the measurements 
will allow the development of early diagnostic tools and novel therapeutics to detect and treat 
neurological conditions years before currently possible.  
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Rapid and sensitive pH measurements based on field-effect transistors (FETs) are used in 
diverse applications that include determining the effects of ocean acidification on marine 
ecology,1 biomanufacturing,2 and low cost DNA sequencers.3 However, drastic improvements in 
sensitivity and the limit of detection (LOD) of electronic pH transduction are needed to 
accelerate their widespread use in important biotechnology applications. One such example is the 
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measurement of the function of enzymes, macromolecular catalysts that accelerate biochemical 
reactions and serve an integral role in ensuring normal cellular function,4 where small changes in 
the solution pH act as a reporter of their function.5,6 Disruptions in normal enzyme function are 
known to give rise to debilitating neurological conditions including Alzheimer’s and 
Parkinsons’s disease,7 several cancers,8 and even chronic neuropathic pain.9 As part of normal 
cellular function, enzymes catalyze the phosphorylation of substrate proteins by the hydrolysis of 
adenosine triphosphate (ATP) and the transfer of a single phosphate group. This results in the 
release of one or more protons into solution, and thereby a small change in the pH. The change in 
pH typically varies by less than 0.005 units10,11 under physiological conditions (i.e., for normal 
living organisms) or an order than magnitude lower than the resolution demonstrated with state-
of-the-art ion-sensitive field effect transistors (ISFETs). 3,12  
Several techniques have been developed over the past century for more accurate 
measurements of solution pH. The Harned cell is the primary pH measurement standard,13 but it 
requires an elaborate setup and long equilibration times making it unusable in the measurement 
of small and fast pH changes. As a result, pH measurements used in biotechnology applications 
rely extensively on electrode measurements or spectrophotometric techniques. These approaches 
lack adequate sensitivity and resolution for accurate measurements of enzyme mediated pH 
changes.14,15 In the past several years, there have been numerous developments in pH sensing 
technology using solid state devices that are potentially suitable for biological 
applications.3,12,16,17 Improved sensitivity and dynamic measurements have been demonstrated 
with ISFETs3 and more recently dual-gate silicon FETs.16 In the latter case, pH sensitivity was 
shown to be approximately two-fold higher than the Nernst potential of 59 mV/pH at room 
temperature.17 Notably, the LOD of ISFETs has been reliably demonstrated to be 0.05 pH 
units.3,12 The LOD for these devices could be lower if the device parameters are optimized18 or if 
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the measurements are performed under a very narrow bandwidth.19 However, resolution that is 
adequate for enzyme measurements under physiological conditions are yet to be experimentally 
realized with silicon FETs. These limitations have required FET-based enzyme catalyzed 
phosphorylation assays to be performed at concentrations that are about two orders of magnitude 
higher than physiological values, precluding their use in diagnostic and therapeutic development 
applications.6,20,21 
Here, we show that FETs with an atomically thin semiconducting channel and gated with an 
ionic liquid (2D-ILFET) allow label-free measurements of enzyme activity and kinetics at or 
below physiological concentrations. The measurements were performed by using a pH sensing 
element that is connected electrically to the 2D-ILFET (Figure 1a). This configuration allowed 
measurements with both a high intrinsic gain16 (i.e., sensitivity) and signal-to-noise ratio (SNR) 
that exceeded comparable silicon devices by more than an two orders of magnitude.22 We show 
that the newly-developed 2D-ILFET measurements are a quantitative first step to enabling their 
use in drug discovery and diagnostic applications. The ability to perform measurements within 
current testing frameworks without resorting to surface modification5,20,23 or hazardous 
radioactive labeling will enable rapid adoption of the method. Furthermore, the higher sensitivity 
of the technique will allow its use in applications beyond enzymatic measurements, for example 
in critically needed early detection of neurodegenerative conditions24 and more broadly to the 
measurements of biomolecular interactions that are important in many applications in biophysics 
and biotechnology.3,25-27 
In order to optimize the use of ionic liquid-gated 2D-ILFETs in enzyme activity 
measurements, we first characterized their electrical performance, followed by sensitive pH 
measurements to validate the approach. The optimized configuration was then used to measure 
 4 
the activity and kinetics of the proline directed kinase Cdk5,28 an enzyme strongly implicated in 
several neurodegenerative conditions. 
Methods 
Device Fabrication and Characterization: Large area, high quality monolayer MoS2 flakes were 
exfoliated from bulk crystal using the gold-mediated exfoliation method29 on to oxidized, heavily 
doped silicon substrates that also served as a global back-gate. SiO2 substrates with a thickness of 
300 nm and 70 nm were used to study the device performance scaling. After the monolayer MoS2 
flakes were located and inspected using an optical microscope, optical photolithography was used 
to pattern the source, drain, and gate electrodes followed by electron beam evaporation of metal 
Ti/Au (2 nm/100 nm) and lift-off in acetone. A second photolithography step was used to define 
the active channel area, followed by reactive ion etching to remove excess MoS2. After a final 
resist cleaning, a small droplet of the DEME-TFSI IL (727679; Sigma Aldrich, St. Louis, MO) 
was carefully applied onto the devices using a micromanipulator under an optical microscope. The 
droplet was sized to cover the MoS2 monolayer and the gate electrodes,30,31 as seen in the optical 
image of the final device in Figure 1b. It is important to note that for good ionic liquid-gate 
coupling with the device’s channel, the area of the gate electrodes that is in contact with the ionic 
liquid was designed to be much larger than the combined area of the source, drain contacts, and 
MoS2 channel that are in contact with the ionic liquid. Gate leakage was verified by measuring the 
current across the ionic liquid upon application of a potential across two patterned gate electrodes. 
The measurement scheme for electrical characterization is shown Figure 1a.  
 
Quantum Capacitance Model: For single layer MoS2 FET under positive ionic liquid-gate bias, 
the relationship between gate voltage, VLG, and the channel charge carrier density, nch, is given 
by32,33  
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where Vt,LG is device threshold voltage, VFB is the flat band voltage, Eg is material band gap, q is 
elementary charge, kB is Boltzalmann’s constant, T is the temperature in Kelvin, g2D is the band 
edge density of states, and CLG is the liquid-gate capacitance. For a fixed VLG, we calculated Vt,LG 
as a function of channel carrier density. 
 𝑉&,#$ = 𝑉#$−𝑉() − F+,-. − /01. 𝑙𝑛 4𝑒𝑥𝑝 8 9:;<=>/01? − 1A + .9:;CDE G (2) 
 
The channel quantum capacitance (CQ) is dependent on the density of charge carriers within the 
channel and is given by,32 
 
𝐶I ≈ 𝑞-𝑔-M N1 + OPQ	S T,=U0VW-XYZ[S\]:;U0V W^
_`
, (3) 
where 𝑉X[ = +,-. − /01. 𝑙𝑛 4𝑒𝑥𝑝 8 9:;<=>/01? − 1A (4) 
 
Using Equations 1—4 we can calculate Vt,LG and CQ as a function of nch. Since CTG and CQ are in 
series as seen from Figure 1e, we calculate CTG(CQ) = CLG´CQ/(CLG+CQ), where CLG is the ionic 
liquid-gate capacitance. Similarly, the back-gate capacitance, CBG = Cox´CQ/(Cox+CQ), where Cox 
is the back-gate oxide capacitance. Moreover, since CQ >> Cox, CBG»Cox=constant. Under these 
limits, the expression for a is given by, 
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and is limited by CQ. At large values of nch, CQ approaches its theoretical limit, CQ,max, and a is 
constant. As nch decreases, CQ decreases exponentially from CQ,max and we observe a 
corresponding reduction in a. The results of the model were compared with experimentally 
measured values of α, which were extracted by taking the numerical derivative of VBG (Vt,LG) 
(Figure 1d and Figure S2; Supplementary Information).  
 
Time-Series Field-Effect Transistor Measurements and PID Control: Time-series 
measurements were performed following the schematic in Figure 2a. The signal on the ionic 
liquid-gate (VLG) was switched between an arbitrary function generator (HF2LI; Zurich 
Instruments, Zurich, Switzerland) or a pH microelectrode (MI-4156; Microelectrodes, Bedford, 
NH). An offset voltage Vo (GS200; Yokogawa Corporation, Tokyo, Japan) was then added to 
VLG using a summing amplifier (SR560; Stanford Research Systems Inc., Sunnyvale, CA).  The 
FET was operated in a constant current mode using a PID controller that varied VBG in response 
to changes in ID. The channel current was first amplified using a current preamplifier (DLPCA-
200; FEMTO, Berlin, Germany) with a transimpedance gain of 106 V/A.  The amplified voltage 
was input to a digital PID controller (HF2LI; Zurich Instruments, Zurich, Switzerland), filtered 
using a 4-pole Bessel low pass filter (LPF) with a bandwidth of 5 kHz and then sampled at 
25 kHz using a 14-bit analog to digital converter. The PID controller varied VBG in response to 
changes in ID with a bandwidth of 1 kHz (KP=496.1, KI=9.242´103 s-1 and KD=8.02 µs). The PID 
output was allowed to vary between -10 V to +10V to drive the back-gate voltage (VBG).  
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Ionic Liquid-Gate C-V Measurements: In order to verify the capacitance (CLG) of the ionic 
liquid, we utilized a LCR meter (E4980A; Agilent, Santa Clara, CA) to make 2-probe, AC 
capacitance measurements across the ionic liquid, measuring across a frequency range of 20 Hz 
to 2 MHz. Figure S3 (see Methods) shows representative results of these capacitive 
measurements, highlighting that at low frequency (where our device operates for sensing) the 
capacitance  constant and approximately 1 nF (see Figure S3, inset; Methods). As seen in the 
inset, we observe a negligible bias dependence of the capacitance at all measured frequencies. 
The capacitance exhibits a less than 1% change over a ± 0.5 V range at the lowest frequency 
(20 Hz). Due to the design of our devices, we do not have a constrained contact area of the ionic 
liquid on electrodes, therefore we utilized optical estimates of ≈100 µm ´ 100 µm as the area of 
metal plates that are in contact with the ionic liquid used in the capacitance measurement. This 
allowed us to estimate the specific gate capacitance to the liquid-gate to be ≈10.7 µF/cm2 at low 
frequency range (20 Hz to 2 kHz), in good agreement with values published in the literature.34  
 
Kinase Measurement Reagents: Static activity measurements of Cdk5/p25 phosphorylation of 
histone H1 were performed by suspending 100 ng of the enzyme (C0745; Sigma Aldrich, MO) in 
50 µL of 1´ kinase buffer to obtain a final concentration of 18.5 nM. The Cdk5/p25 
concentration was reduced five-fold for dynamic measurements to obtain a final concentration of 
3.7 nM. A stock solution of 5´ kinase buffer was prepared by suspending 25 mM b-glycerol 
(G9422; Sigma Aldrich, MO), 50 mM MgCl2 (5980; Millipore, MA), 5 mM EGTA (E0396; 
Sigma Aldrich, MO), 2.4 mM EDTA (1002264786; Sigma Aldrich, MO), 1.25 mM MOPS 
(M1254; Sigma Aldrich, MO) in deionized water (DIW) and diluting further to form 1´ kinase 
buffer. Solutions of the substrate protein were prepared by adding 2 mg/mL of histone H1 
(10223549001; Sigma Aldrich, MO) to the assay to obtain the final concentrations as described 
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in the main text. The phosphorylation reaction was triggered with a cocktail of DTT and ATP. 
The final concentration of the ATP and DTT solution was adjusted to 250 µM and 5 mM in DIW 
respectively. 
 
Cdk5 g-32P-ATP Measurements: Cdk5/p25 (C0745; Sigma Aldrich, MO) kinase activity was 
measured as described in the manufacurer’s protocol with some modifications. The kinase 
reaction was initiated by adding g-32P-ATP (final concentration of 50 µM) to a preincubated 
substrate buffer cocktail and incubated at 30 0C for 1 hour. The reaction was terminated by 
spotting 20 µl of the reaction mixture on a P81 phosphocellulose pad. Dried pads were washed 3 
times in 75 mM phosphoric acid, followed by rinsing with 95% ethanol. The radioactivity of the 
spoted pads was measured in a liquid scintillation counter. Appropriate controls, without added 
phosphoryl acceptor substrates, were also run and the values were subtracted from the total 
counts obtained in the presence of substrate protein. 
 
Results 
Ionic Liquid-Gate 2D FET Performance. Initial characterization of 2D-ILFETs fabricated with 
monolayer MoS235 was performed with the set up in Figure 1a and using a representative device 
seen in Figure 1b (see Methods for fabrication details) where the sensing signal was connected to 
the top ionic liquid gate, while the silicon substrate was used as the measurement gate. The 
devices described in this work are fundamentally different from dual-gate silicon FETs16,36 in 
that the asymmetric, capacitively coupled, gates in the 2D-ILFET control the same atomically 
thin semiconducting channel giving rise to a large intrinsic gain in conjunction with ultralow 
noise performance.  Furthermore, the measurement setup allowed the 2D-ILFET performance to 
approach the intrinsic quantum capacitance limit of the channel material. 
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The transfer characteristics of the device were measured by recording the drain current (ID) as 
a function of the liquid-gate potential (VLG) when the drain voltage (VD) was held constant. The 
measurements were repeated for different back-gate voltages (VBG) to estimate the signal 
amplification (a) due to the asymmetric capacitance of the ionic and back gates (Figure 1c). The 
devices exhibited a dynamic range of »5 orders of magnitude in ID and a subthreshold slope 
between 69 mV/dec and 145 mV/dec at »300 K. 
For each curve in Figure 1c, the liquid-gate threshold voltage (Vt,LG) was estimated from a 
linear extrapolation of the peak transconductance to the x-axis.37 The value of a = dVBG/dVt,LG 
for representative devices was then determined numerically from the data in Figure 1d 
(d=300 nm) and Figure S2 (d=70 nm; see Supplementary Information), where d is the thickness 
of the back-gate dielectric. From Figure 1d we are able to clearly discern two distinct regimes for 
VBG as a function of Vt,LG. At large and positive VBG (Figure 1d; pink), where the device was in 
the limit of large 2D channel carrier density (nch), a was constant and estimated to be 156±3 
(d=300 nm) and 41±4 (d=70 nm). The error bars report the standard error. On the other hand, at 
negative VBG and low nch (Figure 1d; blue), a decreased exponentially. Both regimes of operation 
are explained by the quantum capacitance model discussed next. 
Quantum Capacitance-Limited Performance. For devices with two gates, α can also be 
determined from the ratio of the top (CTG) and bottom gate (CBG) interface capacitances, i.e., α ≈ 
CTG/CBG.16,30,38 For dual-gate FETs where the individual gate oxide capacitances are considerably 
lower than those associated with the channel, α is constant and can be estimated directly from the 
properties of the gate dielectric.34 However, due to the large capacitances associated with ionic 
liquids, for the devices reported here CTG is limited by the intrinsic quantum capacitance (CQ) of 
the 2D semiconducting channel. Importantly, CQ approaches its theoretical limit, CQ,max when nch 
is large.32 Under these conditions a is constant. On the other hand, when nch is reduced, CQ and 
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therefore a decrease exponentially (see Methods for a detailed explanation). This transition 
between the linear and exponential regimes can be observed in terms of the gate voltage in 
Figure 1d and a in Figure 1f. 
 
Figure 1: Electrical characterization of ionic liquid-gate field-effect transistors (FET). Error bars report 
standard errors. (a) Device schematic of an ionic liquid-gated FET for biosensing. A channel formed 
between the source (S) and drain (D) terminals is controlled electrostatically by a voltage applied to the 
silicon substrate (B) or the ionic liquid top-gate (G). A voltage applied to the ionic liquid-gate (VLG) can be 
switched between a voltage source for characterization or a biosensing element. (b) An array of ionic 
liquid dual-gate FETs fabricated using a 2D MoS2 film on a 300 nm SiO2 substrate. The scale bar 
represents 100 µm. (c) Transfer characteristics show the drain current (ID) as a function of VLG and 
varying back-gate voltage (VBG). (d) The change in VBG as a function of liquid-gate threshold voltage 
(Vt,LG). A flat band voltage (VFB) of -0.82 V was subtracted from Vt,LG to enable comparison with theory. (e) 
The dual-gated FET was modeled with three capacitors in series. The quantum capacitance (CQ) of the 
2D channel controls the capacitive coupling between the back (IFB) and liquid (IFL) gate interfaces. (f) A 
plot of a as a function of Vt,LG for two devices with back-gate oxide thickness of 300 nm ( ) and 70 nm (
). The solid line shows the theoretical model for quantum capacitance limited device performance. 
VFB =-0.82 V (d=300 nm) and VFB =+0.12 V (d=70 nm) were subtracted from Vt,LG to allow direct 
comparison of the devices. 
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We see quantitative agreement between the model and measurements for two representative 
device structures shown in Figure 1f. In both cases, we assumed Cox=0.0115  µF/cm2 (d=300 nm) 
and 0.049 µF/cm2 (d=70 nm), and CLG=10.7 µF/cm2 based on our own measurements (Figure S3; 
see Supplementary Information) and literature values.34 CQ,max was directly calculated from 
Equation 5 (see Methods) to be 2.16 µF/cm2, and was in excellent agreement with the value of 
2.2±0.05 µF/cm2 extracted from a non-linear regression of the model to the data in Figure 1f. 
The only other free parameter in the model was the flat band voltage (VFB), which depends in 
part on the fabrication process.39 The extracted value of CQ,max was within ≈45 % of the 
maximum theoretical value for monolayer MoS2, and more than two times higher than previous 
measurements.34,40 This in turn allowed the devices to operate with high sensitivity when used 
for enzyme measurements. Furthermore, the ability to tune a with only the gate voltage is 
advantageous in biosensing applications to allow sensitivity to be offset for higher dynamic 
range. 
 
Figure 2: Constant current mode electrical characterization of dual-gated ionic liquid-gated field-effect 
transistors (FET). (a) The FETs were set up in a constant current mode using a proportional-integral-
derivative (PID) controller. ID was held constant by continually adjusting VBG in response to small changes 
to VLG. (b) The response of VBG, under PID control, as a function of time is shown upon application of a 
1 Hz AC sine wave signal with varying amplitude to the ionic liquid-gate. Data are shown for a back-gate 
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oxide thickness, d=300 nm. (c) The amplification at the back-gate (a) increased with the applied liquid-
gate offset voltage, Vo, allowing the device gain to be smoothly tunable.  The error bars report the 
standard error. (d) The signal-to-noise ratio (SNR) was estimated with a bandwidth of 5 kHz as a function 
of AC signal amplitude for devices operated under PID control and in open loop ( ).  For devices 
fabricated with either 300 nm (a =13;  and a=42; ) or 70 nm (a =5;  and a =50; ) SiO2 back-gate, 
the SNR under PID control was higher than under open loop operation. (e) The limit of pH detection as a 
function of the measurement bandwidth and a for devices with a 70 nm (a =5;  and a =50; ) SiO2 
back-gate dielectric. 
 
Constant Current Operation for Biosensing. The preceding results were used to maximize a 
when operating the ionic liquid FETs in a constant current mode using a proportional-integral-
derivative (PID) controller as shown in Figure 2a. The PID controller varied VBG in response to 
VLG to maintain a root mean square (RMS) channel current of 100 nA. PID performance was 
then compared with open loop operation where ID was recorded in response to changes in VLG. 
The signal connected to the ionic liquid-gate was setup to allow switching between an arbitrary 
waveform generator to calibrate sensor performance or a biosensing element. In both cases, a 
fixed DC offset voltage (Vo) was added to VLG to set the value of a (see Methods).  
Device Sensitivity. Device calibration was performed with a 1 Hz sine wave applied to the 
ionic liquid-gate. Figure 2b shows the change in VBG (d= 300 nm) under PID control with 
Vo=-0.56 V for sine wave amplitudes of VLG ranging from 0.7 to 5.7 mVrms, which resulted in 
a=28. Tuning Vo allowed sensitivity to be smoothly offset for dynamic range with the highest a 
realized when operating near the linear regime determined from Figure 1d. Using this approach, 
we tuned a smoothly from 5±0.4 to 28±1.8 (Figure 2c) when d=300 nm or from 5±0.5 to 50±1.5 
when d=70 nm. Moreover, the measured values of a were consistent with those in Figure 1f, and 
more than an order of magnitude higher than dual-gate silicon FET measurements.16 
Signal-to-Noise Ratio and Limit of Detection. The signal-to-noise ratio (SNR) is a true 
measure of sensor performance. To determine if the higher sensitivity of our FETs, relative to 
dual-gate silicon devices,16 translated to an improved LOD, we measured the noise in VBG and ID  
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of the 2D-ILFET devices as shown in Figure S4. These measurements were then used to estimate 
the SNR of the FET in PID and open loop modes. Figure S4 shows a representative power 
spectral density (PSD) of the back-gate voltage (top) under PID control (d=300 nm) and channel 
current (bottom) during open loop operation. The broadband noise under PID control was 
estimated using the expression 𝛿𝑉)$ = i∫ 𝑆l0E 𝑑𝑓	)o , from DC to the low pass filter bandwidth of 
5 kHz and found to be 5.8 mVrms (d=300 nm; Figure S4 top) and 1.8 mVrms (d=70 nm; Figure S4 
middle) for the measured devices, decreasing as expected with the back-gate oxide thickness. 
Furthermore, dVBG was found to be invariant with Vo and thereby VBG. The channel current noise 
in the open loop case, 𝛿𝐼M = i∫ 𝑆q> 𝑑𝑓	)o   was 700 pArms (Figure S4 bottom). The SNR was 
estimated using the expressions 20 log10(VBG/dVBG) under PID control and 20 log10(Id/dId) in 
open loop mode and shown in Figure 2d as a function of VLG. For a bandwidth of 5 kHz, SNR 
was found to increase »3-fold (a=13, d=300 nm) to »30-fold (a=50, d=70 nm) under PID 
control when compared to open loop operation.  
The LOD of the devices under PID control was estimated as a function of the measurement 
bandwidth when SNR=3 (or »10 dB). This in turn allowed the estimation of the pH resolution 
(dpH) at a temperature of 300 K as seen from Figure 2e. At a bandwidth of 5 kHz, LOD was 
estimated to be 768 µV (a=5, d=70 nm) resulting in dpH=0.013 and only 77 µV (a=50, 
d=70 nm) or dpH=0.0013. Since the measurements of the kinetics of biomolecules are relatively 
slow,  dpH can be further decreased at lower bandwidth. When the signal was measured with a 
bandwidth of 10 Hz (Figure 2e; a=50, d=70 nm), we estimated dpH=82´10-6, representing a 
greater than 10-fold improvement over state-of-the art ISFET measurements.1,12,18,19 Importantly, 
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in contrast to measurements made with dual-gate Si FETs, the LOD improved with increasing a 
as discussed further below. 
The device structures described here are fundamentally different from silicon-based dual-
gated FETs described in previous studies.16,36 In those devices, it was interpreted that two 
channels were formed and controlled independently by the top and bottom gates. In constant 
current mode, when the device was operated in the inversion-inversion regime, changes in the 
gate potential at one interface that drive the corresponding channel into strong inversion 
(increasing channel current), cause the other channel to be placed into weak inversion (with 
higher noise). Regardless of the polarity of the applied potential at the sensing gate, the overall 
channel current noise is dominated by the channel in weak inversion. Channel noise could be 
further limit SNR when the devices are operated in the inversion-depletion regime, for example 
as demonstrated with ultra-thin body double-gated silicon FETs.16 In this case, the noise is 
dominated by the depleted channel and should result in lower performance compared to the 
inversion-inversion regime. Furthermore, this effect becomes more pronounced with increasing 
gain. As a result, extensive work with such devices has shown no measurable improvement in 
SNR of silicon devices despite large improvements in the sensitivity.36 In contrast, ultra-thin 
channels formed with 2D materials have a single conducting channel controlled by both the top 
ionic liquid-gate and bottom SiO2 back-gate. Because the channel can always be placed in the 
inversion regime, the relative noise is low over a wide range of biasing conditions leading to 
improved SNR with these devices.   
Sensitive pH Measurements. The ionic liquid-gate FETs were used to remotely measure the pH 
of buffered solution with high sensitivity. In this measurement, ID was measured as a function of 
VBG when a pH sensor measuring standard buffer solutions was connected to the liquid-gate as 
seen in Figure 3a (inset). The change in the back-gate threshold voltage, Vt,BG  for each measured 
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pH from 4 to 10 is apparent from the data in Figure 3b and was found to be linear (Figure 3a) as 
a function of pH. The measurement sensitivity was estimated to be 4.4 V/pH or »75´ higher than 
the Nernst limit of 59 mV/pH at room temperature17 (Figure 3a; a=159) and is a function of the 
device’s intrinsic a.  
 
 
Figure 3: Ionic liquid-gate field-effect transistor (FET) calibration with buffered pH solutions. (a) The 
change in the back-gate threshold voltage (DVt,BG) as a function of the solution pH showed a linear 
response over the measured range. When using a 300 nm SiO2 back-gate, the pH sensitivity was found 
to be 4.4 V/pH ( ). (inset) Measurements of pH were performed by connecting the ionic liquid-gate (G) to 
a pH sensing element. The dashed line shows the connection to the FET. (b) pH sensitivity of buffered 
electrolyte solutions was extracted from the shift in DVt,BG . Measurements were performed over a wide 
range of solution pH from 4.01 to 10.01. (c) The back-gate voltage (VBG) response to varying pH buffer 
solutions in constant current mode with a bandwidth of 10 Hz is shown when a =33 ( ), resulting in a 
sensitivity of 2.1 V/pH. The error bars represent the standard error. (inset) Time-series measurements of 
VBG response to buffered pH solutions. (d) The measurement signal to noise ratio (SNR) was measured 
at a bandwidth of 10 Hz and found to average 75 dB (»5600). SNR was lowest in the vicinity of neutral 
pH (≈7) where VLG was very small. 
 
The solution pH was also measured in a constant current mode using PID control by setting 
a=33 (Vo=-1.5 V, d=300 nm). Figure 3c (inset) shows time-series measurements of phosphate 
buffered saline (PBS) solution at a bandwidth of 10 Hz. A switch was used to alternatively 
connect the ionic liquid-gate to the PBS solution and to ground. Figure 3c plots the change in 
VBG with solution pH. Measurements were made relative to pH 7 (VLG=0 V); acidic pH resulted 
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in VLG>0 V and basic pH in VLG<0 V. A linear least-squares fit to the data returned a slope of 
2.1 V/pH when a=33. Similar to measurements in Figure 2, sensitivity can be tuned by varying 
Vo to alter a. For example, when a=23 we obtained 1.2 V/pH, which could allow measurements 
over a larger range (data not shown). The maximum value of a obtained in the constant current 
mode was constrained by technical limitations in the control electronics, which precluded 
measurements at the maximum value of a=159 for this device as seen from the static pH 
measurements in Fig. 3a.  
Measurement noise was estimated to be »60 µVrms by integrating the PSD of VBG from DC 
to 10 Hz. The noise spectra when measuring pH did not change substantially from those shown 
in Figure 2. The SNR exhibited a minimum near pH 7 when VLG was small (» 68 dB at a 
sensitivity of 2.1 V/pH; Figure 3d). Based on the pH measurements in Fig. 3 and the noise 
spectra, the LOD of the devices (a=33) were determined to be 92 ´ 10-6 pH units at the noise 
floor (SNR 3; »10 dB) for a bandwidth of 10 Hz. Because the device LOD improves with a as 
seen in Fig. 2, the pH measurements can be further improved in constant current mode by 
increasing a to its theoretical limit of 159 (d=300 nm) and will be explored in future work. 
Enzyme Activity and Kinetics. Protein kinases are an very important subset of enzymes that 
facilitate post translational modifications, such as the phosphorylation of substrate proteins, to 
influence signaling pathways in the cell cycle and achieve homeostasis.4,41 The deregulation of 
protein kinases is believed to underlie the onset of neurological conditions such as Alzheimer’s 
disease or Parkinson’s disease.42,43 Therefore, the functional quantification of enzyme activity is 
central to the development of therapeutics that restore physiological function.44 Existing methods 
to measure enzyme activity, for example during protein phosphorylation, which rely on 
radioactively labeled adenosine triphosphate (ATP) analogs or fluorophores, are expensive 
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because they need specialized molecule labeling and handling, require hours to yield results, and 
often alter the kinase activity, thus limiting their effectiveness in rapid therapeutic screening.45,46 
We applied our ultra-sensitive FET devices to measure the activity and kinetics of the proline 
directed kinase Cdk5. Under normal physiological conditions, Cdk5 is tightly regulated by either 
the p35 or p39 inhibitory proteins.7,47 Oxidative stress causes a 10 kDa membrane anchored 
fragment of p35 to be cleaved, forming the pathological activator p25, resulting in deregulation 
and delocalization of the complex to the cytosol.48 The resulting pathological complex, 
Cdk5/p25, has higher activity than its physiological counterpart, Cdk5/p35, and participates in 
the indiscriminate phosphorylation of numerous proteins, which are known to result in 
neurofibrillary tangles that are a hallmark symptom of Alzheimer’s disease.49 
The multi-protein pathological complex, Cdk5/p25, participates in the phosphorylation 
reaction shown in Figure 4a. Cdk5 mediated phosphorylation results in the release of a proton 
during ATP hydrolysis and the transfer of a single phosphate group to either a serine or threonine 
residue immediately preceding a proline.5 Here, we demonstrate the ability of ionic liquid-gated 
FETs to detect small changes in the solution pH during phosphorylation of the substrate protein, 
histone H1 (see Methods for reagent conditions).  
Enzyme Activity. Figure 4b shows the change in Vt,BG as a function of histone H1 
concentration under steady-state conditions. In each case, Vt,BG was estimated from an ID-VBG 
plot shown in Figure S6 (see Supplementary Information). To account for instrument drift, each 
data point in the figure was measured differentially with a control sample that was identical to 
the measured vials except for the absence of ATP, thereby inhibiting the phosphorylation 
reaction. The kinase activity was then estimated using, 𝑠 = 𝛾 [u`]/f[u`], where k is a constant, [H1] 
is the concentration of histone H1 and g is a scaling constant. For the FET measurements in 
Figure 4b, we estimated k=17.5±1.3 µM from a non-linear regression of the model to the 
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measured data, consistent with previously published activity measurements for the pathological 
Cdk5/p25 complex.10 We compared the measurements in Figure 4b against enzyme activity 
measurements obtained from a radioactively labeled g-32P-ATP assay (see Methods) as seen in 
Figure 4c.50 The estimated value of k=12.1±2.3 µM from those measurements was found to be 
statistically consistent with the FET measurements with 95 % confidence.  
 
Figure 4: Ionic liquid-gate field-effect transistors (FET) were used for label-free enzyme activity and 
kinetics measurements. (a) The proline directed kinase Cdk5 catalyzes the phosphorylation of substrate 
proteins (e.g., histone H1) in the presence of an activator (e.g., p25) and adenosine triphosphate (ATP). 
The hydrolysis of ATP results in the transfer of a single phosphate group to either a serine (Ser) or 
threonine (Thr) residue in the substrate protein and the release of a proton into solution, resulting in a 
change in solution pH. (b) Ionic liquid-gate FETs (a=159) were used to measure the change in solution 
pH as a function of the histone H1 concentration ([H1]), and thereby infer the activity of Cdk5 under 
steady-state conditions.  (c) The FET measurements were in quantitative agreement with a 
complementary assay that used radioactively labeled g- 32P-ATP as a reporter of Cdk5 activity. (d) Time-
series measurements of enzyme catalyzed phosphorylation as a function of [H1] (9.1 µM, ; 12.7 µM, ; 
18.2 µM, ) are shown and allow the direct estimation of the reaction dynamics. The solid lines depict the 
reaction kinetics model that describes the time course of phosphorylation, while the dashed lines 
represent an estimate of the reaction velocity during the first 100 s after a change in the signal was 
detected. 
 
We estimated the change in the solution pH for the FET measurements from DVt,BG in Figure 
4b (a=159). The expected change in the solution pH was estimated using the expression w[ux]w	yu =
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−2.303	 C~~[ux](~f[ux])=, where Ca is the buffer concentration, Ka is the acid dissociation constant and 
[H+] is the proton concentration.11,51 The change in pH was consistent with »3 phosphorylation 
sites on the substrate protein, assuming an electrolyte solution buffered with Ca=250 µM 3-(N-
morpholino)propanesulfonic acid (MOPS). 
Enzyme Kinetics. The FET-based measurements have a response time that allows the direct 
estimation of reaction kinetics and velocities as seen from Figure 4d and Figure S6 (see 
Supplementary Information). The concentration of the Cdk5/p25 complex in these measurements 
was 3.8 µM (5-fold lower than the quantity used in Figure 4b and c). A control sample without 
histone showed no change in the measured potential upon addition of ATP (data not shown). 
From Figure 4d, we observed that upon addition of ATP there was a decrease in VBG after 
»2 min. The polarity of VBG is consistent with the release of protons into solution, which results 
in an increase in VLG. The initial reaction velocities were estimated from a linear regression of 
the first 100 s data after a change in VBG was detected and were found to increase monotonically 
with [H1]. Furthermore, the initial linear change in VBG is consistent with an enzyme limited 
reaction.52 Finally, the time-course of each reaction in Figure 4d was fit with a first order rate 
law of the form, 𝑉)$ = 𝛽(1 − 𝑒_/	&), where b is a scaling constant and k1 is a rate constant. The 
rate constant was consistent with previously reported values52,53 and estimated to be 
k1=0.18±0.02 per min, independent of the histone H1 concentration. FET-based measurements 
are in excellent quantitative agreement with existing techniques as seen from Figure 4, while 
enabling results in minutes. 
Conclusions. We have demonstrated that dual-gate FETs with atomically thin channels and ionic 
liquid top-gates allow performance limited by the intrinsic quantum capacitance of the channel 
material, providing a robust and sensitive biosensing platform. The nearly 100-fold improvement 
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in pH sensitivity above the Nernst value and order of magnitude improvement in the LOD over 
state-of-the-art silicon ISFETs at a bandwidth of 10 Hz allowed the measurement of small 
changes in solution pH during enzyme mediated phosphorylation under physiological conditions. 
The method eliminates the need for specialized labeling and hazardous material handling and can 
decrease the cost and complexity of assays appreciably. Another key advantage of the 
measurements is that they are time-resolved, enabling the estimation of both enzyme activity and 
kinetics in a single assay. Because signal transduction is performed remotely, the measurements 
are compatible with standard microtiter plates, and therefore amenable for use in high throughput 
screening to allow rapid evaluation of pharmaceutical candidates for neurological diseases. 
The high sensitivity and SNR allowed measurements with 5-fold lower enzyme 
concentrations than physiological values and over an order of magnitude below previous 
demonstrations using FET. This in turn will enable new biomarker diagnostics from blood or 
cerebrospinal fluid to be developed for use at early stages of  neurodegeneration where the 
changes to kinase activity are subtle and currently undetectable.54,55 Importantly, these 
measurements can allow testing several years before any observable decline in cognitive 
function, allowing early interventions to be developed. The extended gate configuration of the 
sensors permit remote measurements, which allow them to be adapted for use in cell and tissue 
culture assays, where an increase in kinase activity has been correlated with pH imbalances.56 
Such measurements can allow assays that interrogate mechanistic behavior across multiple 
spatial scales – from test tube to cell culture experiments – to better quantify the origin of disease 
states.57  
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